Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial.

导出 OA

翻译打印收藏纠错

第一作者： Mandeep S,Dhingra

第一单位： Department of Pediatrics, 1St. Johns Medical College Hospital Bangalore, Karnataka, India.

作者： Mandeep S,Dhingra ^[1] ; Raman,Rao ; Swarnarekha,Bhat ; Rajan,Joshi ; Veena,Kalra ; Harish R,Parikh ; S Narasimha,Rao ; G R,Sethi ; Nitin,Shah ; M,Muzaffaruddin

作者单位： Department of Pediatrics, 1St. Johns Medical College Hospital Bangalore, Karnataka, India. ^[1]

主题词抗体, 细菌(Antibodies, Bacterial);白喉-破伤风-百日咳菌苗(Diphtheria-Tetanus-Pertussis Vaccine);水肿(Edema);女(雌)性(Female);发热(Fever);嗜血菌菌苗(Haemophilus Vaccines);人类(Humans);免疫接种, 加强(Immunization, Secondary);印度(India);婴儿(Infant);男(雄)性(Male);疼痛(Pain);接种(Vaccination)

DOI 10.4161/hv.6.7.11817

PMID 20421723

发布时间 2021-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览12

Human vaccines

2010年6卷7期

572-7页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial.

Human vaccines

相似文献

Human vaccines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial.

Human vaccines

相似文献

Human vaccines

相关期刊

检索历史清除